07.04.2016 - The targeted $160 billion merger between Pfizer and Allergan has run afoul of new anti-inversion legislation proposed by the US Treasury, as had been predicted by most deal...
Advertising Opportunities Print, Digital & Content Solutions
LinkedIn | X (Twitter)